Northern Trust (KEQU holder) discloses 8.8% Kewaunee Scientific ownership

Rhea-AI Filing Summary

Northern Trust Corporation reported beneficial ownership of 252,328 shares of Kewaunee Scientific common stock, representing 8.8% of the outstanding class as of 12/31/2025. Northern Trust has sole voting and dispositive power over 15,967 shares and shared power over 236,361 shares.

The shares were acquired and are held in the ordinary course of business, and Northern Trust certifies they are not held for the purpose or effect of changing or influencing control of Kewaunee Scientific.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 7)

KEWAUNEE SCIENTIFIC CORP /DE/

(Name of Issuer)

Common Stock, $2.50 par value per share

(Title of Class of Securities)

492854104

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 492854104

1

Names of Reporting Persons

NORTHERN TRUST CORP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 15,967.00
6	Shared Voting Power 236,361.00
7	Sole Dispositive Power 15,967.00
8	Shared Dispositive Power 236,361.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

252,328.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.8 %

12

Type of Reporting Person (See Instructions)

BK, HC

SCHEDULE 13G

Item 1.
(a)	Name of issuer: KEWAUNEE SCIENTIFIC CORP /DE/
(b)	Address of issuer's principal executive offices: 2700 W FRONT ST, STATESVILLE, NORTH CAROLINA, 28677.
Item 2.
(a)	Name of person filing: Northern Trust Corporation
(b)	Address or principal business office or, if none, residence: 50 South LaSalle Street Chicago, IL 60603
(c)	Citizenship: US
(d)	Title of class of securities: Common Stock, $2.50 par value per share
(e)	CUSIP No.: 492854104
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 252328
(b)	Percent of class: 8.8 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 15967
	(ii) Shared power to vote or to direct the vote: 236361
	(iii) Sole power to dispose or to direct the disposition of: 15967
	(iv) Shared power to dispose or to direct the disposition of: 236361
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. The Northern Trust Company 50 South LaSalle Street Chicago, IL 60603
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

NORTHERN TRUST CORP

Signature:	Michael Hunstad
Name/Title:	Executive Vice President
Date:	02/13/2026

FAQ

What stake does Northern Trust hold in Kewaunee Scientific (KEQU)?

Northern Trust Corporation beneficially owns 252,328 shares of Kewaunee Scientific common stock, representing 8.8% of the class. This level of ownership requires public disclosure on Schedule 13G/A under SEC rules for significant shareholders.

How much voting power does Northern Trust report in KEQU shares?

Northern Trust reports sole voting power over 15,967 Kewaunee Scientific shares and shared voting power over 236,361 shares. This split indicates some shares are controlled directly, while others are voted jointly with clients or other parties.

Is Northern Trust seeking control of Kewaunee Scientific (KEQU)?

Northern Trust certifies the KEQU shares were acquired and are held in the ordinary course of business, not to change or influence control. It also states the holdings are not connected with any control-related transaction or activist nomination, except as allowed under specified SEC rules.

What is the significance of the 8.8% ownership in KEQU?

Owning 8.8% of Kewaunee Scientific makes Northern Trust a significant institutional holder under SEC thresholds. This triggers Schedule 13G/A reporting, giving investors transparency about large positions that may influence trading liquidity and shareholder votes.

Who signed the Schedule 13G/A for Northern Trust regarding KEQU?

The Schedule 13G/A for Kewaunee Scientific was signed by Michael Hunstad, Executive Vice President of Northern Trust. His signature certifies, after reasonable inquiry, that the reported ownership information is true, complete, and correct as of the stated date.